Cargando…

Survivin Promoter Polymorphism (-31 C/G): A Genetic Risk Factor for Oral Cancer

BACKGROUND: The polymorphism of survivin gene at its promoter region is one of the risk factors for OSCC . This polymorphism involves substitution of G for C (9904341), and it is present at the cell cycle dependent elements and cell cycle homology region repressor binding motif of promoter. This stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehdi, Rehana Faryal, Sheikh, Fouzia, Khan, Rizma, Fawad, Bina, Haq, Ahteshaam Ul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948886/
https://www.ncbi.nlm.nih.gov/pubmed/31031231
http://dx.doi.org/10.31557/APJCP.2019.20.4.1289
_version_ 1783485817908363264
author Mehdi, Rehana Faryal
Sheikh, Fouzia
Khan, Rizma
Fawad, Bina
Haq, Ahteshaam Ul
author_facet Mehdi, Rehana Faryal
Sheikh, Fouzia
Khan, Rizma
Fawad, Bina
Haq, Ahteshaam Ul
author_sort Mehdi, Rehana Faryal
collection PubMed
description BACKGROUND: The polymorphism of survivin gene at its promoter region is one of the risk factors for OSCC . This polymorphism involves substitution of G for C (9904341), and it is present at the cell cycle dependent elements and cell cycle homology region repressor binding motif of promoter. This study aimed to find the association between survivin -31C/G polymorphism and prevalence of OSCC in a subset of Pakistani population. METHODOLOGY: This case-control study was conducted on 47 cases with and 101 healthy individuals with no family history of cancer. We used polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) protocols. RESULTS: The most common site of oral cancer in our research was the buccal mucosa followed by tongue and the least one was the labial mucosa. The histological tumor type of all 47 cases was squamous cell type. In our research, stage II had the highest prevalence, accounting for 34% of patients, while the prevalence of stage I was 31% in the case group. The prevalence of stage III and IV was 25% and 8%, respectively. The numbers of moderately and poorly differentiated tumors were equal. We found a significant association between the CC genotype of survivin and OSCC prevalence (OR was 9.395 at 95% CI: 1.0202-86.5251, p-value= 0.04). The GG genotype also showed significant P value (OR: 0.4709 with 95% CI: 0.2323- 0.9546 at a P VALUE of 0.0367). while no significant P value was noted for CG genotype (OR: 1.4317 with 95% CI: 0.7513 -2.8658, p- value= 0.31). CONCLUSION: Survivin -31G/C polymorphism was strongly associated with OSCC prevalence. The C allele was more common in case group as compared to healthy individuals living in Pakistan.
format Online
Article
Text
id pubmed-6948886
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-69488862020-02-04 Survivin Promoter Polymorphism (-31 C/G): A Genetic Risk Factor for Oral Cancer Mehdi, Rehana Faryal Sheikh, Fouzia Khan, Rizma Fawad, Bina Haq, Ahteshaam Ul Asian Pac J Cancer Prev Research Article BACKGROUND: The polymorphism of survivin gene at its promoter region is one of the risk factors for OSCC . This polymorphism involves substitution of G for C (9904341), and it is present at the cell cycle dependent elements and cell cycle homology region repressor binding motif of promoter. This study aimed to find the association between survivin -31C/G polymorphism and prevalence of OSCC in a subset of Pakistani population. METHODOLOGY: This case-control study was conducted on 47 cases with and 101 healthy individuals with no family history of cancer. We used polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) protocols. RESULTS: The most common site of oral cancer in our research was the buccal mucosa followed by tongue and the least one was the labial mucosa. The histological tumor type of all 47 cases was squamous cell type. In our research, stage II had the highest prevalence, accounting for 34% of patients, while the prevalence of stage I was 31% in the case group. The prevalence of stage III and IV was 25% and 8%, respectively. The numbers of moderately and poorly differentiated tumors were equal. We found a significant association between the CC genotype of survivin and OSCC prevalence (OR was 9.395 at 95% CI: 1.0202-86.5251, p-value= 0.04). The GG genotype also showed significant P value (OR: 0.4709 with 95% CI: 0.2323- 0.9546 at a P VALUE of 0.0367). while no significant P value was noted for CG genotype (OR: 1.4317 with 95% CI: 0.7513 -2.8658, p- value= 0.31). CONCLUSION: Survivin -31G/C polymorphism was strongly associated with OSCC prevalence. The C allele was more common in case group as compared to healthy individuals living in Pakistan. West Asia Organization for Cancer Prevention 2019 /pmc/articles/PMC6948886/ /pubmed/31031231 http://dx.doi.org/10.31557/APJCP.2019.20.4.1289 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mehdi, Rehana Faryal
Sheikh, Fouzia
Khan, Rizma
Fawad, Bina
Haq, Ahteshaam Ul
Survivin Promoter Polymorphism (-31 C/G): A Genetic Risk Factor for Oral Cancer
title Survivin Promoter Polymorphism (-31 C/G): A Genetic Risk Factor for Oral Cancer
title_full Survivin Promoter Polymorphism (-31 C/G): A Genetic Risk Factor for Oral Cancer
title_fullStr Survivin Promoter Polymorphism (-31 C/G): A Genetic Risk Factor for Oral Cancer
title_full_unstemmed Survivin Promoter Polymorphism (-31 C/G): A Genetic Risk Factor for Oral Cancer
title_short Survivin Promoter Polymorphism (-31 C/G): A Genetic Risk Factor for Oral Cancer
title_sort survivin promoter polymorphism (-31 c/g): a genetic risk factor for oral cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948886/
https://www.ncbi.nlm.nih.gov/pubmed/31031231
http://dx.doi.org/10.31557/APJCP.2019.20.4.1289
work_keys_str_mv AT mehdirehanafaryal survivinpromoterpolymorphism31cgageneticriskfactorfororalcancer
AT sheikhfouzia survivinpromoterpolymorphism31cgageneticriskfactorfororalcancer
AT khanrizma survivinpromoterpolymorphism31cgageneticriskfactorfororalcancer
AT fawadbina survivinpromoterpolymorphism31cgageneticriskfactorfororalcancer
AT haqahteshaamul survivinpromoterpolymorphism31cgageneticriskfactorfororalcancer